Tissue Engineering to Treat Corneal Blindness

Cornea Biosciences focuses on developing innovative therapies for corneal diseases, leveraging advanced technologies to enhance ocular health. Their pipeline includes a range of products aimed at addressing various corneal conditions, utilizing cutting-edge approaches such as regenerative medicine and tissue engineering. These technologies are designed to promote healing and restore vision, offering new hope for patients suffering from corneal disorders.

The company emphasizes the importance of scientific research in its development process, employing a robust understanding of corneal biology to inform their product development. By integrating insights from molecular biology and biochemistry, Cornea Biosciences aims to create effective treatments that not only alleviate symptoms but also target the underlying causes of corneal diseases. Their commitment to innovation and scientific rigor positions them as a leader in the field of ocular therapeutics.

United States

The Cornea Biosciences biosynthetic replacement corneal will help reduce world corneal blindness.  More than 15 years of research have gone into development of the Company's cornea.  It will provide a safe, affordable, biocompatible cornea for the millions of people unable to obtain corneal transplants due to a severe shortage of human corneas.

30211 Avenida de las Banderas, Suite 200, Rancho Santa Margarita, California 92688, US

Cornea Biosciences

Company Details